Weinstein M J, Chute L E
J Clin Invest. 1984 Feb;73(2):307-16. doi: 10.1172/JCI111215.
We have characterized Factor VIII coagulant protein, present in normal human plasma, that reacts with a specific human 125I-labeled anti-human VIII:C antigen Fab antibody fragment. Two major Factor VIII coagulant antigen populations were present. The first, approximately 85% of the total antigen, was bound to von Willebrand factor and when tested in a standard one-stage assay had Factor VIII coagulant activity. The second antigenic population, eluting near fibrinogen when plasma was gel filtered, was not bound to von Willebrand protein, did not have Factor VIII coagulant activity unless activated, but did block anti-VIII:C Fab neutralization of clotting activity. The two antigenic populations were separable by cryoprecipitation and agarose gel electrophoresis. Although the two antigenic populations differed in their Factor VIII coagulant activity and in their binding to von Willebrand factor, the principal member of both populations is of mol wt 2.4 X 10(5). Both antigens, when proteolyzed by thrombin, were quickly converted to a 1 X 10(5)-mol wt form in association with the appearance of VIII:C activity. The 1 X 10(5)-mol wt antigen was further slowly degraded to an 8 X 10(4)-mol wt form while Factor VIII coagulant activity declined. These results demonstrate the presence of an inactive Factor VIII coagulant protein in plasma, not associated with von Willebrand factor, that can react with thrombin to yield Factor VIII coagulant activity.
我们已对正常人血浆中存在的凝血因子VIII凝血蛋白进行了特性分析,该蛋白可与一种特异性的人125I标记的抗人VIII:C抗原Fab抗体片段发生反应。存在两种主要的凝血因子VIII凝血抗原群体。第一种,约占总抗原的85%,与血管性血友病因子结合,在标准的一期试验中检测时具有凝血因子VIII凝血活性。第二种抗原群体,在血浆进行凝胶过滤时在纤维蛋白原附近洗脱,不与血管性血友病蛋白结合,除非被激活否则不具有凝血因子VIII凝血活性,但可阻断抗VIII:C Fab对凝血活性的中和作用。这两种抗原群体可通过冷沉淀和琼脂糖凝胶电泳分离。尽管这两种抗原群体在凝血因子VIII凝血活性及其与血管性血友病因子的结合方面存在差异,但两个群体的主要成分的分子量均为2.4×10⁵。两种抗原经凝血酶蛋白水解后,均迅速转化为分子量为1×10⁵的形式,并伴随VIII:C活性的出现。分子量为1×10⁵的抗原进一步缓慢降解为分子量为8×10⁴的形式,同时凝血因子VIII凝血活性下降。这些结果表明血浆中存在一种不与血管性血友病因子相关的无活性凝血因子VIII凝血蛋白,它可与凝血酶反应产生凝血因子VIII凝血活性。